Feasibility study for 2nd line combination chemotherapy of Nab-paclitaxel with Ramucirumab for inoperable advanced recurrent gastric cancer.
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2017
At a glance
- Drugs Paclitaxel (Primary) ; Ramucirumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 07 Nov 2017 Status changed from not yet recruiting to recruiting.
- 12 Jul 2016 New trial record